# GNOM holdings: all 50 positions

> All 50 GNOM holdings with weights, as of May 31, 2026. The top 3 are Guardant Health Inc 5.59%, ILMN 4.82% and NTRA 4.15%. Free CSV download.

Data as of May 31, 2026. Rebuilt every trading night.

GNOM held 50 positions as of May 31, 2026. Guardant Health Inc is the largest at 5.59%; the top 10 are 42.5% of the fund.

Source: Form N-PORT filed with the SEC (https://www.sec.gov/Archives/edgar/data/1432353/000204825126006502/primary_doc.xml).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | Guardant Health Inc | GH | 5.59% |
| 2 | Illumina Inc | ILMN | 4.82% |
| 3 | Natera Inc | NTRA | 4.15% |
| 4 | BioMarin Pharmaceutical Inc | BMRN | 4.09% |
| 5 | Arrowhead Pharmaceuticals Inc | ARWR | 4.07% |
| 6 | Legend Biotech Corp | LEGN | 4.04% |
| 7 | Praxis Precision Medicines Inc | PRAX | 4.01% |
| 8 | Twist Bioscience Corp | TWST | 3.97% |
| 9 | Vertex Pharmaceuticals Inc | VRTX | 3.95% |
| 10 | CRISPR Therapeutics AG | CRSP | 3.85% |
| 11 | Veracyte Inc | VCYT | 3.64% |
| 12 | Qiagen N.V. | QGEN | 3.54% |
| 13 | BioNTech SE | BNTX | 3.41% |
| 14 | Bio-Techne Corp | TECH | 3.41% |
| 15 | Moderna Inc | MRNA | 3.28% |
| 16 | 10X Genomics Inc | TXG | 3.23% |
| 17 | Beam Therapeutics Inc | BEAM | 3.09% |
| 18 | Eli Lilly & Co | LLY | 2.31% |
| 19 | Ultragenyx Pharmaceutical Inc | RARE | 2.25% |
| 20 | Caris Life Sciences Inc | CAI | 2.03% |
| 21 | Genscript Biotech Corp |  | 2.00% |
| 22 | BillionToOne Inc |  | 1.97% |
| 23 | Gilead Sciences Inc | GILD | 1.95% |
| 24 | Astrazeneca PLC |  | 1.83% |
| 25 | Sarepta Therapeutics Inc | SRPT | 1.80% |
| | Cash and other net assets | | 0.10% |

The largest 25 of 50 positions are shown. All of them: https://etfiq.com/funds/gnom/holdings/gnom-holdings.csv (CSV) or https://etfiq.com/data/books/gnom.json (JSON).

Fund page: https://etfiq.com/funds/gnom

Cite: ETFIQ, Holdings of GNOM, data as of May 31, 2026. https://etfiq.com/funds/gnom/holdings/